{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T01:08:18Z","timestamp":1774314498207,"version":"3.50.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,29]]},"DOI":"10.7759\/cureus.102572","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T18:08:01Z","timestamp":1769710081000},"source":"Crossref","is-referenced-by-count":1,"title":["An Atypical Presentation of Guillain-Barr\u00e9 Syndrome: Bilateral Facial Nerve Palsy With Preserved Reflexes"],"prefix":"10.7759","author":[{"given":"Ali","family":"Al-Timimy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahwa","family":"Farooqui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alia","family":"Choudhry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anil","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00517-1","article-title":"Guillain-Barr\u00e9 syndrome","volume":"397","author":"Shahrizaila N","year":"2021","unstructured":"Shahrizaila N, Lehmann HC, Kuwabara S. Guillain-Barr\u00e9 syndrome. Lancet. 2021, 397:1214-28. 10.1016\/S0140-6736(21)00517-1","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.24887","article-title":"Isolated facial diplegia in Guillain-Barr\u00e9 syndrome: bifacial weakness with paresthesias","volume":"52","author":"Wakerley BR","year":"2015","unstructured":"Wakerley BR, Yuki N. Isolated facial diplegia in Guillain-Barr\u00e9 syndrome: bifacial weakness with paresthesias. Muscle Nerve. 2015, 52:927-32. 10.1002\/mus.24887","journal-title":"Muscle Nerve"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(13)70215-1","article-title":"Axonal Guillain-Barr\u00e9 syndrome: concepts and controversies","volume":"12","author":"Kuwabara S","year":"2013","unstructured":"Kuwabara S, Yuki N. Axonal Guillain-Barr\u00e9 syndrome: concepts and controversies. Lancet Neurol. 2013, 12:1180-8. 10.1016\/S1474-4422(13)70215-1","journal-title":"Lancet Neurol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.58.6.893","article-title":"Anticipating mechanical ventilation in Guillain-Barr\u00e9 syndrome","volume":"58","author":"Lawn ND","year":"2001","unstructured":"Lawn ND, Fletcher DD, Henderson RD, Wolter TD, Wijdicks EF. Anticipating mechanical ventilation in Guillain-Barr\u00e9 syndrome. Arch Neurol. 2001, 58:893-8. 10.1001\/archneur.58.6.893","journal-title":"Arch Neurol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.05.119","article-title":"Vaccine-preventable diseases, vaccines and Guillain-Barre' syndrome","volume":"37","author":"Principi N","year":"2019","unstructured":"Principi N, Esposito S. Vaccine-preventable diseases, vaccines and Guillain-Barre' syndrome. Vaccine. 2019, 37:5544-50. 10.1016\/j.vaccine.2018.05.119","journal-title":"Vaccine"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000207282","article-title":"CSF findings in relation to clinical characteristics, subtype, and disease course in patients with Guillain-Barr\u00e9 syndrome","volume":"100","author":"Al-Hakem H","year":"2023","unstructured":"Al-Hakem H, Doets AY, Stino AM, et al.. CSF findings in relation to clinical characteristics, subtype, and disease course in patients with Guillain-Barr\u00e9 syndrome. Neurology. 2023, 100:e2386-97. 10.1212\/WNL.0000000000207282","journal-title":"Neurology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1114525","article-title":"Guillain-Barr\u00e9 syndrome","volume":"366","author":"Yuki N","year":"2012","unstructured":"Yuki N, Hartung HP. Guillain-Barr\u00e9 syndrome. N Engl J Med. 2012, 366:2294-304. 10.1056\/NEJMra1114525","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2024.1123","article-title":"Expanding clinical spectrum of anti-GQ1b antibody syndrome: a review","volume":"81","author":"Lee SU","year":"2024","unstructured":"Lee SU, Kim HJ, Choi JY, Choi KD, Kim JS. Expanding clinical spectrum of anti-GQ1b antibody syndrome: a review. JAMA Neurol. 2024, 81:762-70. 10.1001\/jamaneurol.2024.1123","journal-title":"JAMA Neurol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr6702a1","article-title":"Prevention of pertussis, tetanus, and diphtheria with vaccines in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"67","author":"Liang JL","year":"2018","unstructured":"Liang JL, Tiwari T, Moro P, Messonnier NE, Reingold A, Sawyer M, Clark TA. Prevention of pertussis, tetanus, and diphtheria with vaccines in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2018, 67:1-44. 10.15585\/mmwr.rr6702a1","journal-title":"MMWR Recomm Rep"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.05.036","article-title":"An assessment of the safety of adolescent and adult tetanus-diphtheria-acellular pertussis (Tdap) vaccine, using active surveillance for adverse events in the Vaccine Safety Datalink","volume":"27","author":"Yih WK","year":"2009","unstructured":"Yih WK, Nordin JD, Kulldorff M, Lewis E, Lieu TA, Shi P, Weintraub ES. An assessment of the safety of adolescent and adult tetanus-diphtheria-acellular pertussis (Tdap) vaccine, using active surveillance for adverse events in the Vaccine Safety Datalink. Vaccine. 2009, 27:4257-62. 10.1016\/j.vaccine.2009.05.036","journal-title":"Vaccine"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.61.6.736","article-title":"Practice parameter: immunotherapy for Guillain-Barr\u00e9 syndrome: report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"61","author":"Hughes RA","year":"2003","unstructured":"Hughes RA, Wijdicks EF, Barohn R, et al.. Practice parameter: immunotherapy for Guillain-Barr\u00e9 syndrome: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2003, 61:736-40. 10.1212\/wnl.61.6.736","journal-title":"Neurology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1177\/0194599813505967","article-title":"Clinical practice guideline: Bell's palsy","volume":"149","author":"Baugh RF","year":"2013","unstructured":"Baugh RF, Basura GJ, Ishii LE, et al.. Clinical practice guideline: Bell's palsy. Otolaryngol Head Neck Surg. 2013, 149:S1-27. 10.1177\/0194599813505967","journal-title":"Otolaryngol Head Neck Surg"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/PEC.0000000000001648","article-title":"Pediatric bilateral facial paralysis: an unusual presentation of Lyme disease","volume":"36","author":"Wong K","year":"2020","unstructured":"Wong K, Sequeira S, Bechtel K. Pediatric bilateral facial paralysis: an unusual presentation of Lyme disease. Pediatr Emerg Care. 2020, 36:e651-3. 10.1097\/PEC.0000000000001648","journal-title":"Pediatr Emerg Care"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-019-09387-w","article-title":"Differential diagnosis of peripheral facial nerve palsy: a retrospective clinical, MRI and CSF-based study","volume":"266","author":"Zimmermann J","year":"2019","unstructured":"Zimmermann J, Jesse S, Kassubek J, Pinkhardt E, Ludolph AC. Differential diagnosis of peripheral facial nerve palsy: a retrospective clinical, MRI and CSF-based study. J Neurol. 2019, 266:2488-94. 10.1007\/s00415-019-09387-w","journal-title":"J Neurol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1055\/s-0041-1726358","article-title":"Approach to facial weakness","volume":"41","author":"Wang Y","year":"2021","unstructured":"Wang Y, Cruz CD, Stern BJ. Approach to facial weakness. Semin Neurol. 2021, 41:673-85. 10.1055\/s-0041-1726358","journal-title":"Semin Neurol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/PRS.0000000000002599","article-title":"Bilateral facial paralysis: a 13-year experience","volume":"138","author":"Gaudin RA","year":"2016","unstructured":"Gaudin RA, Jowett N, Banks CA, Knox CJ, Hadlock TA. Bilateral facial paralysis: a 13-year experience. Plast Reconstr Surg. 2016, 138:879-87. 10.1097\/PRS.0000000000002599","journal-title":"Plast Reconstr Surg"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/450470-an-atypical-presentation-of-guillain-barr-syndrome-bilateral-facial-nerve-palsy-with-preserved-reflexes","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T18:08:02Z","timestamp":1769710082000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/450470-an-atypical-presentation-of-guillain-barr-syndrome-bilateral-facial-nerve-palsy-with-preserved-reflexes"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,29]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.102572","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,29]]}}}